Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II chemoradiotherapy for locally advanced or relapsed vulvar carcinoma
2004-005218-35Phase 2Active
- Sponsor
- Nordic Society of Gynaecological Oncology
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cisplatin in Vulval carcinoma, sponsored by Nordic Society of Gynaecological Oncology. Primary endpoint: Infield disease control. Started Mar 2006; status: active.
02
Drugs
cisplatin
03
Conditions
Vulval carcinoma
Beyond the preview
Go deeper on 2004-005218-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-005218-35.